Hypoglycemic AgentsDrug CombinationsDiabetes Mellitus, Type 1Diabetes MellitusDiabetes Mellitus, Type 2Drug SynergismDiabetes ComplicationsDiabetes Mellitus, ExperimentalDrug Therapy, CombinationDrug InteractionsDiabetes, GestationalBlood GlucoseHemoglobin A, GlycosylatedAntineoplastic Combined Chemotherapy ProtocolsInsulinProguanilMethenamineDiabetes InsipidusAntimalarialsDose-Response Relationship, DrugRisk FactorsDrug TherapyDapsoneArtemisininsAntineoplastic AgentsCell Line, TumorAtovaquoneHyperglycemiaDrug Screening Assays, AntitumorTreatment OutcomeTime FactorsMethylthioinosineCyclopentolateDrug AntagonismTropicamideCellophaneGlucose Tolerance TestDiabetic NephropathiesIslets of LangerhansSulfamethoxazoleDrug ResistancePrediabetic StatePyrimethamineMefloquinePyrazinesDiabetic RetinopathyObesityInsulin ResistancePharmaceutical PreparationsDrug Evaluation, PreclinicalInsulin-Secreting CellsInhibitory Concentration 50Mice, Inbred NODMolecular Targeted TherapyDiabetic NeuropathiesStreptozocinFloxuridineCell SurvivalApoptosisSulfadoxineBlood Glucose Self-MonitoringHypertensionCisplatinPregnancy in DiabeticsPrevalenceRifampinAntihypertensive AgentsNanoconjugatesMicrobial Sensitivity TestsAmodiaquineXenograft Model Antitumor AssaysPhentermineDrug Administration ScheduleBody Mass IndexChloroquineAmikacinDisease Models, AnimalGlucose IntoleranceUnited StatesFluorouracilSesquiterpenesBoronic AcidsDoxorubicinMetforminNiacinamideCohort StudiesNaphthoquinonesAntifungal AgentsNeoplasmsHypoglycemiaPyrimidinesSelf Care